14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

P.Hadji; A.Kauka; M.Kalder; T.Bauer; U.Albert; M.Muth; M.Ziller

首页> 外文期刊>European Journal of Cancer Supplements >14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

【24h】

14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

机译：14唑来膦酸对激素受体阳性或阴性乳腺癌，新辅助或辅助化疗或内分泌治疗的绝经前妇女骨矿物质密度的影响

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第3期|共1页
作者
P.Hadji; A.Kauka; M.Kalder; T.Bauer; U.Albert; M.Muth; M.Ziller;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment [J] . P.Hadji, A.Kauka, M.Kalder, European Journal of Cancer Supplements . 2010,第3期

机译：14唑来膦酸对激素受体阳性或阴性乳腺癌，新辅助或辅助化疗或内分泌治疗的绝经前妇女骨矿物质密度的影响
2. 5056 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment [J] . M.Ziller, P.Hadji, K.Kauka, European Journal of Cancer Supplements . 2009,第2期

机译：5056唑来膦酸对患有激素受体阳性或阴性乳腺癌，新辅助或辅助化疗或内分泌治疗的绝经前妇女骨矿物质密度的影响
3. 5056 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment [J] . M.Ziller, P.Hadji, K.Kauka, European Journal of Cancer Supplements . 2009,第2期

机译：5056唑来膦酸对患有激素受体阳性或阴性乳腺癌，新辅助或辅助化疗或内分泌治疗的绝经前妇女骨矿物质密度的影响
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. Changes in bone mineral density in men with prostate cancer during treatment with luteinizing hormone-releasing hormone (LHRH) agonist monotherapy. [D] . Conde, Francisco Alcasid, II. 2003

机译：黄体激素释放激素（LHRH）激动剂单药治疗期间前列腺癌男性的骨矿物质密度变化。
6. Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials [O] . Meredith M. Regan, Prudence A. Francis, Olivia Pagani, -1

机译：绝经前妇女接受激素受体阳性人表皮生长因子受体2阴性早期乳腺癌的辅助内分泌疗法的绝对益处：TEXT和SOFT试验
7. Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor–positive, human epidermal growth factor receptor 2–negative early breast cancer: TEXT and SOFT Trials [O] . Regan, Meredith M., Francis, Prudence A., Pinotti, Graziella, 2016

机译：辅助内分泌疗法对绝经前激素受体阳性，人表皮生长因子受体2阴性的早期乳腺癌的绝对益处：TEXT和SOFT试验

14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

著录项

相似文献

相关主题

期刊订阅